Nephros (NEPH) Return on Capital Employed Growth (5y) (2016 - 2026)
Nephros (NEPH) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.11 Bn | 120.90 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.96 Bn | 44.15 Bn | 2.15 Bn |
| 3 | Alcon | 33.16 Bn | 31.50 Bn | 1.53 Bn |
| 4 | Medline | 33.00 Bn | 30.76 Bn | 1.84 Bn |
| 5 | Resmed | 29.51 Bn | 27.85 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.50 Bn | 23.06 Bn | 329.20 Mn |
| 7 | Solventum | 14.07 Bn | 13.51 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.92 Bn | 13.78 Bn | 735.40 Mn |
| 9 | Align Technology | 12.14 Bn | 11.08 Bn | 736.59 Mn |
| 10 | Nephros | 36.43 Mn | 32.41 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,143.00 |
| Dec 31, 2025 | 3,822.00 |
| Sep 30, 2025 | 4,242.00 |
| Jun 30, 2025 | 3,761.00 |
| Mar 31, 2025 | 3,204.00 |
| Dec 31, 2024 | 3,450.00 |
| Sep 30, 2024 | 3,154.00 |
| Jun 30, 2024 | 2,908.00 |
| Mar 31, 2024 | 2,881.00 |
| Dec 31, 2023 | 2,399.00 |
| Sep 30, 2023 | 2,169.00 |
| Jun 30, 2023 | 3,341.00 |
| Mar 31, 2023 | 5,679.00 |
| Dec 31, 2022 | 6,508.00 |
| Sep 30, 2022 | 13,357.00 |
| Jun 30, 2022 | 8,979.00 |
| Mar 31, 2022 | 9,314.00 |
| Dec 31, 2021 | 12,337.00 |
| Sep 30, 2021 | 9,066.00 |
| Jun 30, 2021 | 12,228.00 |